No abstract available
Keywords:
COVID-19; SARS-CoV-2; TMPRSS2; prostate cancer.
MeSH terms
-
Androgens / metabolism
-
Angiotensin-Converting Enzyme 2
-
Betacoronavirus / metabolism
-
Betacoronavirus / pathogenicity
-
COVID-19
-
COVID-19 Drug Treatment
-
Carcinogenesis / pathology
-
Coronavirus Infections / drug therapy
-
Coronavirus Infections / pathology*
-
Coronavirus Infections / transmission
-
Coronavirus Infections / virology
-
Disease Progression
-
Esters
-
Estrogens / metabolism
-
Gabexate / analogs & derivatives
-
Gabexate / pharmacology
-
Gabexate / therapeutic use
-
Gene Expression Regulation, Neoplastic
-
Guanidines
-
Humans
-
Lung / pathology
-
Lung / virology
-
Male
-
Oncogene Proteins, Fusion / genetics
-
Pandemics
-
Peptidyl-Dipeptidase A / metabolism*
-
Pneumonia, Viral / drug therapy
-
Pneumonia, Viral / pathology*
-
Pneumonia, Viral / transmission
-
Pneumonia, Viral / virology
-
Polymorphism, Single Nucleotide
-
Prostate / pathology
-
Prostatic Neoplasms / genetics
-
Prostatic Neoplasms / mortality
-
Prostatic Neoplasms / pathology*
-
Protease Inhibitors / pharmacology
-
Protease Inhibitors / therapeutic use
-
RNA-Seq
-
SARS-CoV-2
-
Serine Endopeptidases / genetics
-
Serine Endopeptidases / metabolism*
-
Spike Glycoprotein, Coronavirus / metabolism*
-
Virus Internalization / drug effects
Substances
-
Androgens
-
Esters
-
Estrogens
-
Guanidines
-
Oncogene Proteins, Fusion
-
Protease Inhibitors
-
Spike Glycoprotein, Coronavirus
-
TMPRSS2-ERG fusion protein, human
-
spike protein, SARS-CoV-2
-
camostat
-
Gabexate
-
Peptidyl-Dipeptidase A
-
ACE2 protein, human
-
Angiotensin-Converting Enzyme 2
-
Serine Endopeptidases
-
TMPRSS2 protein, human